Beyond carboplatin/paclitaxel: Choice of adjuvant chemotherapy regimen in mucinous ovarian carcinoma

被引：0
|
作者：
Barkdull, Savannah [1 ]
Zhang, Yingao [1 ]
Legarreta, Alejandra Flores [2 ]
Frumovitz, Michael [2 ]
Sood, Anil [2 ]
机构：
[1] Baylor Coll Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2232
引用
收藏
页码：S350 / S350
页数：1
相关论文
共 50 条
  • [1] Chemotherapy for ovarian cancer: Beyond paclitaxel plus carboplatin
    Ozols, RF
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (06): : 336 - 338
  • [2] Choice of adjuvant chemotherapy following neoadjuvant carboplatin/paclitaxel and interval debulking
    Roque, D. M.
    Schwab, C. L.
    Goloubeva, O.
    English, D. P.
    Black, J. D.
    Silasi, D. A.
    Azodi, M.
    Rutherford, T. J.
    Santin, A.
    Schwartz, P. E.
    Ratner, E. S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 106 - 107
  • [3] Adjuvant chemotherapy comprising a paclitaxel and carboplatin regimen or paclitaxel and ifosfamide regimen for uterine carcinosarcoma, a single institutional retrospective study
    Ohtake, Y.
    Nishikawa, T.
    Yoshida, H.
    Ishikawa, M.
    Ikeda, S.
    Kato, T.
    Shimomura, A.
    Shimoi, T.
    Noguchi, E.
    Yonemori, K.
    Shimizu, C.
    Yunokawa, M.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus
    Bozas, GT
    Bamias, A
    Kastritis, E
    Rodolakis, A
    Vlahos, G
    Papadimitriou, CA
    Markaki, S
    Dimopoulos, MA
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (06) : 627 - 631
  • [5] Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
    Lee, Matilda X.
    Tan, David S. P.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (06)
  • [6] Progressive Multifocal Leukoencephalopathy After Carboplatin and Paclitaxel Chemotherapy for Ovarian Carcinoma
    Menon, Poornima Jayadev
    McKenna, Mary Clare
    Murphy, Sean
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (10) : 554 - +
  • [7] Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer
    Shechter-Maor, Gil
    Bruchim, Ilan
    Ben-Harim, Zipi
    Altaras, Marco
    Fishman, Ami
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) : 662 - 664
  • [8] ENDOMETRIOID ENDOMETRIAL CARCINOMA WITH LYMPH NODE METASTASIS TREATED WITH ADJUVANT PACLITAXEL/CARBOPLATIN CHEMOTHERAPY
    Otsuka, I.
    Matsuura, T.
    Enmi, S.
    Suemitsu, T.
    Suzuki, Y.
    Teraoka, K.
    Furusawa, Y.
    Shimizu, Y.
    Kameda, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1539 - 1539
  • [9] Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer
    Shafer, A.
    Rubatt, J. M.
    Ayeni, T.
    Deal, A. M.
    Secord, A. A.
    Soper, J. T.
    Havrilesky, L. J.
    Van Le, L.
    Gehring, P. A.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S55 - S56
  • [10] Improved survival with consolidation chemotherapy after adjuvant paclitaxel and carboplatin in advanced epithelial ovarian cancer
    Shafer, A.
    Ayeni, T. A.
    Deal, A. M.
    Secord, A. Alvarez
    Soper, J. T.
    Havrilesky, L. J.
    Van Le, L.
    Gehrig, P. A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S135 - S136
12345